GB1318859A - Imidazo-4,5-b-pyridine derivatives - Google Patents
Imidazo-4,5-b-pyridine derivativesInfo
- Publication number
- GB1318859A GB1318859A GB4400371A GB4400371A GB1318859A GB 1318859 A GB1318859 A GB 1318859A GB 4400371 A GB4400371 A GB 4400371A GB 4400371 A GB4400371 A GB 4400371A GB 1318859 A GB1318859 A GB 1318859A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- prepared
- reacting
- pyridine
- imidazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7034133A FR2105060A1 (en) | 1970-09-21 | 1970-09-21 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
FR7130825A FR2150236A2 (en) | 1971-08-25 | 1971-08-25 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1318859A true GB1318859A (en) | 1973-05-31 |
Family
ID=26215952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4400371A Expired GB1318859A (en) | 1970-09-21 | 1971-09-21 | Imidazo-4,5-b-pyridine derivatives |
Country Status (13)
Country | Link |
---|---|
AU (1) | AU453067B2 (fr) |
BE (1) | BE772835A (fr) |
CA (1) | CA940131A (fr) |
CH (1) | CH532600A (fr) |
DE (1) | DE2147103C3 (fr) |
DK (1) | DK131345B (fr) |
ES (2) | ES395260A1 (fr) |
GB (1) | GB1318859A (fr) |
HU (1) | HU163150B (fr) |
IL (1) | IL37752A (fr) |
LU (1) | LU63927A1 (fr) |
NL (1) | NL145553B (fr) |
SE (1) | SE368828B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194430B1 (en) | 1999-03-31 | 2001-02-27 | The Procter & Gamble Company | Viral treatment |
WO2001089499A2 (fr) * | 2000-05-25 | 2001-11-29 | The Procter & Gamble Company | Traitement du cancer |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593466B1 (en) | 1999-07-07 | 2003-07-15 | Isis Pharmaceuticals, Inc. | Guanidinium functionalized nucleotides and precursors thereof |
-
1971
- 1971-09-17 IL IL37752A patent/IL37752A/en unknown
- 1971-09-20 HU HURO628A patent/HU163150B/hu unknown
- 1971-09-20 LU LU63927D patent/LU63927A1/xx unknown
- 1971-09-20 DK DK458771AA patent/DK131345B/da unknown
- 1971-09-20 BE BE772835A patent/BE772835A/fr unknown
- 1971-09-20 CH CH1372371A patent/CH532600A/fr not_active IP Right Cessation
- 1971-09-20 SE SE11891/71A patent/SE368828B/xx unknown
- 1971-09-20 CA CA123264A patent/CA940131A/en not_active Expired
- 1971-09-21 DE DE2147103A patent/DE2147103C3/de not_active Expired
- 1971-09-21 ES ES395260A patent/ES395260A1/es not_active Expired
- 1971-09-21 GB GB4400371A patent/GB1318859A/en not_active Expired
- 1971-09-21 NL NL717112971A patent/NL145553B/xx unknown
- 1971-09-21 AU AU33735/71A patent/AU453067B2/en not_active Expired
-
1972
- 1972-06-15 ES ES403910A patent/ES403910A1/es not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194430B1 (en) | 1999-03-31 | 2001-02-27 | The Procter & Gamble Company | Viral treatment |
WO2001089499A2 (fr) * | 2000-05-25 | 2001-11-29 | The Procter & Gamble Company | Traitement du cancer |
US6384049B1 (en) | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
WO2001089499A3 (fr) * | 2000-05-25 | 2002-07-18 | Procter & Gamble | Traitement du cancer |
Also Published As
Publication number | Publication date |
---|---|
ES395260A1 (es) | 1973-12-01 |
LU63927A1 (fr) | 1972-06-27 |
AU453067B2 (en) | 1974-09-19 |
IL37752A0 (en) | 1971-11-29 |
IL37752A (en) | 1974-10-22 |
DK131345B (da) | 1975-06-30 |
DK131345C (fr) | 1975-11-24 |
NL145553B (nl) | 1975-04-15 |
SE368828B (fr) | 1974-07-22 |
CH532600A (fr) | 1973-01-15 |
HU163150B (fr) | 1973-06-28 |
DE2147103B2 (de) | 1974-11-14 |
NL7112971A (fr) | 1972-03-23 |
CA940131A (en) | 1974-01-15 |
ES403910A1 (es) | 1975-05-01 |
BE772835A (fr) | 1972-03-20 |
AU3373571A (en) | 1973-03-29 |
DE2147103C3 (de) | 1975-07-17 |
DE2147103A1 (de) | 1972-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES345981A1 (es) | Procedimiento para la obtencion de alimentos para aves. | |
GB1425354A (en) | Indole derivatives | |
GB1456627A (en) | Pyridobenzodiazepinones | |
GB1297386A (fr) | ||
GB1448026A (en) | 2-aminomethyleneindanone analgesic agents | |
GB1318859A (en) | Imidazo-4,5-b-pyridine derivatives | |
GB1341809A (en) | Phenanthridine derivatives | |
ES273438A1 (es) | Un procedimiento para la producciën de 3-fenoxipropilguanidina y sus sales por adiciën de acido | |
GB1255098A (en) | Derivatives of glycyrrhetinic acid | |
GB1112909A (en) | Ergoline derivatives | |
GB1299566A (en) | Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones | |
GB1375378A (fr) | ||
GB1254270A (en) | Benzoxazepine derivatives | |
GB1322069A (en) | Aminoalkanoylaminocyclohexane derivatives | |
GB1173809A (en) | N-Substituted Nor-Morphines | |
GB1304164A (fr) | ||
GB1369888A (en) | Substituted amidines | |
GB1297273A (fr) | ||
GB976719A (en) | New derivatives of heparin and processes for their preparation | |
GB947001A (en) | Substituted phenoxyalklylguanidines | |
GB1284582A (en) | Substituted piperazinopyrimidinones | |
GB1209138A (en) | IMPROVEMENTS IN OR RELATING TO A NEW alpha-NAPHTHOXY-ISOBUTYRIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND THERAPEUTICAL COMPOSITION CONTAINING SAME | |
GB1426500A (en) | Fluorinated 3-keto-glycyrrhetinic acid derivatives | |
ES375975A1 (es) | Procedimiento para la preparacion del monosemiester de aci-do sulfurico del bis-(4 - hidroxifenil) - (piridil-2) - me- tano y del semiester de acido sulfurico del (4-hidroxifenil) - (4-metoxifenil) - (piridil-2)-metano y de sus sales | |
GB1398564A (en) | 1-amino substituted-1-cycloalkane derivatives of 6-amino penicillanic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |